Since 70% of heritable and 15–40% of apparently sporadic PAH develop on the basis of monoallelic bone morphogenetic protein type 2 receptor (Bmpr2) mutations, Bmpr2 is recognized as the major genetic risk factor for developing PAH [3]. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.